![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Beyond the AJR: Should Imaging-Based Risk Assessment Tools Be Used in Lung Cancer
Screening?
AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.23.29060.
PubMed
Cardiac Metastasis From Solid Cancers: A 35-Year Single-Center Autopsy Study.
Arch Pathol Lab Med. 2023;147:177-184.
PubMed
Abstract available
Spectral CT-based radiomics signature for distinguishing malignant pulmonary
nodules from benign.
BMC Cancer. 2023;23:91.
PubMed
Abstract available
The prognostic value of the advanced lung cancer inflammation index in patients
with gastrointestinal malignancy.
BMC Cancer. 2023;23:101.
PubMed
Abstract available
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early
diagnosis of lung adenocarcinoma.
BMC Cancer. 2023;23:110.
PubMed
Abstract available
A cell fate reprogramming strategy reverses epithelial-to-mesenchymal transition
of lung cancer cells while avoiding hybrid states.
Cancer Res. 2023 Sep 13:CAN-22-1559. doi: 10.1158/0008-5472.CAN-22-1559.
PubMed
Abstract available
Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of
Patients with Osteosarcoma.
Clin Cancer Res. 2023;29:659-666.
PubMed
Abstract available
Old Dog, New Trick: A Tumor-Intrinsic Role for PD-1 in Chemoresistant Tumor
Subclones.
Clin Cancer Res. 2023;29:505-507.
PubMed
Abstract available
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus
CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.
Clin Cancer Res. 2023;29:548-559.
PubMed
Abstract available
18FDG PET/CT Tumoral and Neurologic Therapeutic Response in a Case of Anti-GABABR
Paraneoplastic Limbic Encephalitis.
Clin Nucl Med. 2023;48:237-239.
PubMed
Abstract available
The Humeral Metastasis as the Initial Presentation of Lung Adenocarcinoma
Revealed by 18F-FDG PET/CT.
Clin Nucl Med. 2023;48:280-281.
PubMed
Abstract available
PET/CT Manifestations of a Case of Penicilliosis Marneffei Misdiagnosed as Lung
Cancer.
Clin Nucl Med. 2023 Jan 12. doi: 10.1097/RLU.0000000000004531.
PubMed
Abstract available
Tumor location predicts occult N1 nodal metastases in clinical stage I non-small
cell lung cancer: is location alone sufficient to justify limiting the extent of
resection.
Eur J Cardiothorac Surg. 2023 Feb 1:ezad033. doi: 10.1093.
PubMed
Long-term Survival Outcomes after Lobe-specific Nodal Dissection in Patients with
Early Non-Small Cell Lung Cancer.
Eur J Cardiothorac Surg. 2023 Jan 30:ezad016. doi: 10.1093.
PubMed
Abstract available
Feasibility and effectiveness of segmentectomy versus wedge resection for
clinical stage I non-small cell lung cancer.
Eur J Cardiothorac Surg. 2023 Jan 27:ezad018. doi: 10.1093.
PubMed
Abstract available
Preoperative visualization of congenital lung abnormalities: hybridizing
artificial intelligence and virtual reality.
Eur J Cardiothorac Surg. 2022;63:ezad014.
PubMed
Abstract available
Stage IV lung cancer: the relevance of tumour profile for the construction of
prognostic groups.
Eur Respir J. 2023;61:2202094.
PubMed
Optimised surveillance of minor to moderate bronchial dysplasia in a risky
population: more precision strategies needed.
Eur Respir J. 2023;61:2202264.
PubMed
Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in
mice models and in patients with mesothelioma.
Int J Cancer. 2023;152:1438-1443.
PubMed
Abstract available
Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant
tumors.
Int J Cancer. 2023;152:1463-1475.
PubMed
Abstract available
Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma.
Int J Cancer. 2023;152:1490-1500.
PubMed
Abstract available
The impact of Body Mass Index (BMI) and residence in Food Priority Areas (FPAs)
on patterns-of-care and cancer outcomes in patients with stage III non-small cell
lung cancer.
Int J Radiat Oncol Biol Phys. 2023 Jan 28:S0360-3016(23)00080.
PubMed
Abstract available
Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to
predict lymph node metastasis of resectable T2-4 NSCLC.
J Cancer Res Clin Oncol. 2023;149:247-261.
PubMed
Abstract available
Novel immunogenic cell death-related risk signature to predict prognosis and
immune microenvironment in lung adenocarcinoma.
J Cancer Res Clin Oncol. 2023;149:307-323.
PubMed
Abstract available
Extracranial metastasis sites correlate to the incidence risk of brain metastasis
in stage IV non-small cell lung cancer: a population-based study.
J Cancer Res Clin Oncol. 2023 Feb 2. doi: 10.1007/s00432-022-04548.
PubMed
Abstract available
Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma
Following Chemotherapy: A Report From the International PPB/DICER1 Registry.
J Clin Oncol. 2023;41:778-789.
PubMed
Abstract available
Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance
Against Osimertinib (FLAURA)?
J Clin Oncol. 2023;41:742-744.
PubMed
Progression-Free Survival or Failure of Local Treatment Strategy: End Points for
Trials Testing Stereotactic Body Radiotherapy.
J Clin Oncol. 2023;41:938-939.
PubMed
A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A
Decision Curve Analysis.
J Clin Oncol. 2023;41:826-834.
PubMed
Abstract available
Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic
Toxicity in Older Adults With Advanced Cancer.
J Clin Oncol. 2023;41:835-846.
PubMed
Abstract available
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung
Cancer: Updated Results From the Phase III Randomized ADAURA Trial.
J Clin Oncol. 2023 Jan 31:JCO2202186. doi: 10.1200/JCO.22.02186.
PubMed
Abstract available
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year
Update of the Phase III KEYNOTE-407 Study.
J Clin Oncol. 2023 Feb 3:JCO2201990. doi: 10.1200/JCO.22.01990.
PubMed
Abstract available
The Intersection of Lung Cancer Screening, Radiomics, and Artificial
Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer?
J Clin Oncol. 2023 Feb 3:JCO2202885. doi: 10.1200/JCO.22.02885.
PubMed
Neither surveillance nor treatment showed significant survival benefit for lung
metastases from colorectal cancer, imaging guided thermal ablation is a safe and
efficient alternative to surgery.
J Surg Oncol. 2022 Nov 17. doi: 10.1002/jso.27148.
PubMed
Finding that outcomes after imaging-guided thermal ablation and surgery for
colorectal lung metastases are similar does not prove a survival benefit from
either.
J Surg Oncol. 2023;127:510-512.
PubMed
Non-small cell lung cancer disparities in stage at presentation and treatment for
Asian American, Native Hawaiian, and Pacific Islander women.
J Surg Oncol. 2023 Jan 31. doi: 10.1002/jso.27204.
PubMed
Abstract available
Treatment outcomes of older participants in a randomized trial comparing two
schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung
cancer.
J Thorac Oncol. 2023 Jan 27:S1556-0864(23)00016.
PubMed
Abstract available
Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung
Cancer to PD-L1 Blockade.
JAMA Oncol. 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7586.
PubMed
Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung
Cancer to PD-L1 Blockade-Reply.
JAMA Oncol. 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7589.
PubMed
Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung
Cancer to PD-L1 Blockade.
JAMA Oncol. 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7583.
PubMed
Pseudoprogression of a cutaneous lung cancer metastasis.
Lancet Oncol. 2023;24:e102.
PubMed
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha,
for the Treatment of Ovarian and Endometrial Cancers.
Mol Cancer Ther. 2023;22:155-167.
PubMed
Abstract available
Correlation between metastatic patterns and age in patients with metastatic
primary liver cancer: A population-based study.
PLoS One. 2023;18:e0267809.
PubMed
Abstract available
CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic
vulnerabilities in solid tumors.
Proc Natl Acad Sci U S A. 2023;120:e2212072120.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by